Pyroxamide

CAS No. 382180-17-8

Pyroxamide( —— )

Catalog No. M20956 CAS No. 382180-17-8

Pyroxamide is an histone deacetylases (HDACs) inhibitor with antineoplastic properties ( HDAC1;IC50: 0.1-0.2 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 39 In Stock
10MG 68 In Stock
25MG 146 In Stock
50MG 251 In Stock
100MG 443 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pyroxamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Pyroxamide is an histone deacetylases (HDACs) inhibitor with antineoplastic properties ( HDAC1;IC50: 0.1-0.2 μM).
  • Description
    Pyroxamide is an histone deacetylases (HDACs) inhibitor with antineoplastic properties ( HDAC1;IC50: 0.1-0.2 μM).
  • In Vitro
    Cell Viability Assay Cell Line:RD cells; RH30B cells Concentration:1.25-20.0 μM Incubation Time:24 hours; 48 hours; 72 hours Result:Resulted in a cell growth decrease in RD and RH30B cells.Cell Cycle Analysis Cell Line:RD cells; RH30B cells Concentration:10.0 μM; 20.0 μM Incubation Time:48 hours Result:Increased the sub-G1?fractions at 48 hours compared with control samples.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    382180-17-8
  • Formula Weight
    265.31
  • Molecular Formula
    C13H19N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (471.15 mM)
  • SMILES
    O=C(CCCCCCC(=O)Nc1cccnc1)NO
  • Chemical Name
    N1-hydroxy-N8-(pyridin-3-yl)octanediamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Butler L M Webb Y Agus D B et al. Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide an inhibitor of histone deacetylase[J]. Clinical Cancer Research 2001 7(4):962-970.
molnova catalog
related products
  • HDAC1,2-IN-2

    A potent, selective HDAC1 and HDAC2 inhibitor with IC50 of 6 nM and 45 nM, respectively.

  • Ledipasvir

    Ledipasvir is a Hepatitis C Virus NS5A Inhibitor. The mechanism of action of ledipasvir is as a P-Glycoprotein Inhibitor, and Breast Cancer Resistance Protein Inhibitor.

  • HDACi-4b

    A benzamide-type HDAC inhibitor with IC50 of 78 uM for changes of FXN mRNA in affected GM15850 cells.